White Paper: Evaluation of the Oncomine BRCA Research Assay for variant detection by next-generation sequencing
Fill out the short form below to access the white paper and learn more about:
- Important inherited and somatic mutations in BRCA1/2, their associations with several cancer types, and their importance as biomarkers for approved cancer therapies
- The technology behind the Oncomine BRCA Research Assay, which enables automated, rapid sequencing with low DNA input from blood, cell lines, or FFPE samples
- The sensitivity and specificity of the assay in the detection of SNVs, MNVs, indels, and whole-exon, multiple-exon, or entire-gene aberrations
- Ion Reporter Software and Ion Torrent Oncomine Reporter informatics packages